Targacept confirms Stephen Hill as president and chief executive
November 27, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, stephen hill
Clinical-stage biopharma firm Targacept has announced that Stephen Hill has been appointed as president and chief executive. Hill is expected …
Glass particles force recall of Ranbaxy Lipitor
November 27, 2012Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall
Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …
UCB sells Indian production plant to Exemed
November 27, 2012Manufacturing and Production API, Exemed, UCB, vapi
UCB Pharma has signed a deal to sell its manufacturing facility in Vapi, India, to local firm Exemed Pharmaceuticals. The …
MPs pharma investigation in offing
November 26, 2012Sales and Marketing ABPI, Bad pharma, M&P, MP, NICE, trial data
A health select committee inquiry into pharma companies withholding clinical trial data is being considered, according to committee chair Stephen …
Summit appoints two non-executive directors
November 26, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frank Armstrong, Jim Mellon, summit
UK drug discovery and development firm Summit has appointed Jim Mellon and Dr Frank Armstrong as non-executive directors. The additions …
Vifor ad breaches Code
November 26, 2012Sales and Marketing ABPI, PMCPA, Vifor, ferinject
Vifor has been blasted after failing to adhere to an earlier ruling made under the ABPI’s Code of Practice. Such …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
Burson-Marsteller appoints Kate Hawker as MD and chair
November 23, 2012Medical Communications, Sales and Marketing Burson-Marsteller
PR firm Burson-Marsteller has hired pharma comms expert Kate Hawker as managing director and chair of both its EMEA and …
NICE medicines uptake dissected
November 23, 2012Sales and Marketing HSCIC, IMS, NICE
Lack of diagnosis, ignoring required tests, muddled commissioning and local policy variations are among the key reasons why NICE-approved drugs …
GSK’s Promacta extends US licence
November 22, 2012Sales and Marketing FDA, GSK, Promacta, Revolade
GlaxoSmithKline’s Promacta has received a new indication from the FDA which means it can be used for patients with thrombocytopenia …
Further indications for Eliquis
November 22, 2012Sales and Marketing BMS, Eliquis, NVAF, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer’s oral blood-thinner Eliquis has been approved in Europe to prevent stroke in patients with nonvalvular atrial …
Jim Easton steps down from NHS Commissioning Board role
November 22, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Easton, NHS, NHS Commissioning Board
Jim Easton has stepped down from his role as national director: Transformation at the NHS Commissioning Board (CB) and his …
New NHS, new customers – tips from the frontline
November 21, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCGs, Commissioning Board, Dixon, NHS, Sobanja, pharmafile
In the noisy and continuing debate over health reform, it is worth remembering the aim of the coalition government’s health …
Xarelto gets new EU approval
November 21, 2012Sales and Marketing AF, Bayer, DVT, Xarelto
Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …
Almirall appoints first woman to its Board
November 21, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall
Karin Louise Dorrepaal is the first woman to join Almirall’s ten-member Board of directors. Dorrepaal, who is Dutch, has extensive …
Pfizer in cystic fibrosis alliance
November 21, 2012Research and Development, Sales and Marketing CFFT, CFTR, FDA, Pfizer
Pfizer and Cystic Fibrosis Foundation Therapeutics (CFFT) have signed a six-year pre-clinical deal to find new drugs to treat the …
Avastin shows brain cancer benefit
November 20, 2012Research and Development, Sales and Marketing Cancer, FDA, Merck, Roche, avastin, brain
In a Phase III trial, Roche’s Avastin has helped people with newly-diagnosed glioblastoma (GBM) live longer without their disease worsening. …
Catalent wields axe at UK plant
November 20, 2012Manufacturing and Production CTS, Catalent, Swindon
Around 45 staff at Catalent’s pharmaceutical facility in Swindon, UK, are to lose their jobs because of fluctuating demand for …
Pharma manufacturing news in brief
November 20, 2012Manufacturing and Production Alfa Laval, Boehringer, Fujifilm, Health Canada, Novartis
Our latest round-up of manufacturing news includes a facility contract for Alfa Laval, plus updates from Fujifilm, Novartis, Boehringer Ingelheim …
Senior appointments at NHS Commissioning Board
November 20, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, CCGs, NHS
The NHS Commissioning Board (NHS CB) has made several national appointments to the Medical Directorate. Barry Cockcroft (currently chief dental …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
